Phase 2 Metastatic Non-squamous Non Small Cell Lung Cancer trials recruiting now

All Metastatic Non-squamous Non Small Cell Lung Cancer trials, every phase

Phase 2 Metastatic Non-squamous Non Small Cell Lung Cancer trials

• Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
  NCT06463665 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
  NCT07246863 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 34 locations
• Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
  NCT07098988 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 42 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.